Levothyroxine

Generic Name
Levothyroxine
Brand Names
Eltroxin, Ermeza, Euthyrox, Levo-T, Levothroid, Levoxyl, Np Thyroid, Synthroid, Thyquidity, Tirosint, Unithroid
Drug Type
Small Molecule
Chemical Formula
C15H11I4NO4
CAS Number
51-48-9
Unique Ingredient Identifier
Q51BO43MG4
Background

Levothyroxine is a synthetically produced form of thyroxine, a major endogenous hormone secreted by the thyroid gland. Also known as L-thyroxine or the brand name product Synthroid, levothyroxine is used primarily to treat hypothyroidism, a condition where the thyroid gland is no longer able to produce sufficient quantities of the thyroid hormones T (tetraio...

Indication

Levothyroxine is indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. It is also indicated as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.

Associated Conditions
Edematous Fibrosclerotic Panniculopathy (Cellulite), Hypothyroidism, Localized Adiposity, Myxedema coma, Euthyroid Goitre, Thyrotropin dependent Well-Differentiated Thyroid Cancer
Associated Therapies
-

Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism

First Posted Date
2013-04-15
Last Posted Date
2018-09-12
Lead Sponsor
Shandong Provincial Hospital
Target Recruit Count
400
Registration Number
NCT01831869
Locations
🇨🇳

Shandong Provincial Hospital, Jinan, Shandong, China

Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment

First Posted Date
2012-12-04
Last Posted Date
2012-12-04
Lead Sponsor
Walter Reed National Military Medical Center
Target Recruit Count
180
Registration Number
NCT01739972
Locations
🇺🇸

Walter Reed National Military Medical Center, Endocrinology, Bethesda, Maryland, United States

🇺🇸

Walter Reed National Military Medical Center, Bethesda, Maryland, United States

Thyroid Hormone Replacement for Subclinical Hypothyroidism

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-08-08
Last Posted Date
2017-03-13
Lead Sponsor
NHS Greater Glasgow and Clyde
Target Recruit Count
737
Registration Number
NCT01660126
Locations
🇬🇧

Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom

Study of Optimal Replacement of Thyroxine in the Elderly

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-07-24
Last Posted Date
2015-10-12
Lead Sponsor
Newcastle-upon-Tyne Hospitals NHS Trust
Target Recruit Count
48
Registration Number
NCT01647750
Locations
🇬🇧

Clinical Research Facility, Newcastle upon Tyne, Tyne and Wear, United Kingdom

🇬🇧

Bensham Hospital, Gateshead, Tyne and Wear, United Kingdom

Levothyroxine for Children With Euthyroid Sick Syndrome

First Posted Date
2012-06-29
Last Posted Date
2014-03-05
Lead Sponsor
Sinaloa Pediatric Hospital
Target Recruit Count
80
Registration Number
NCT01631305
Locations
🇲🇽

Sinaloa Pediatric Hospital, Culiacan, Sinaloa, Mexico

Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-02-22
Last Posted Date
2013-02-11
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
26
Registration Number
NCT01536678
Locations
🇮🇳

GSK Investigational Site, Hyderabad, India

Supraphysiological Doses of Levothyroxine as Adjunctive Therapy in Bipolar Depression

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-02-08
Last Posted Date
2012-02-08
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
74
Registration Number
NCT01528839
Locations
🇩🇪

Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, Dresden, Germany

🇺🇸

University of California in Los Angeles, Los Angeles, California, United States

🇩🇪

Department of Psychiatry, LWL University Hospital, Ruhr University Bochum, Bochum, Germany, Bochum, Germany

and more 2 locations

Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensitive CRP

First Posted Date
2011-12-06
Last Posted Date
2011-12-08
Lead Sponsor
King Saud University
Target Recruit Count
200
Registration Number
NCT01486667
Locations
🇸🇦

University Sleep Disorders Center, Riyadh, Saudi Arabia

Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 100 μg/ 75 μg Tablets

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-11-06
Last Posted Date
2011-11-06
Lead Sponsor
Heidelberg University
Target Recruit Count
24
Registration Number
NCT01465646
Locations
🇩🇪

Clinical Research Unit, University of Heidelberg, Heidelberg, Germany

Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-11-06
Last Posted Date
2011-11-06
Lead Sponsor
Heidelberg University
Target Recruit Count
24
Registration Number
NCT01465633
Locations
🇩🇪

Clinical Research Unit, University of Heidelberg, Heidelberg, Germany

© Copyright 2024. All Rights Reserved by MedPath